Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II/III study of M605101 in acne vulgaris
jRCT2080221742Phase 3
- Sponsor
- Maruho Co., Ltd.
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in acne vulgaris comparing M605101 with Placebo (2 arms).
02
Drugs
trifarotene
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on jRCT2080221742.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221742.